Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells

Rossella Loria, Giulia Bon, Valentina Perotti, Enzo Gallo, Ilaria Bersani, Paola Baldassari, Manuela Porru, Carlo Leonetti, Selene Di Carlo, Paolo Visca, Maria Felice Brizzi, Andrea Anichini, Roberta Mortarini, Rita Falcioni

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

We used whole genome microarray analysis to identify potential candidate genes with differential expression in BRAFV600E vs NRASQ61R melanoma cells. We selected, for comparison, a peculiar model based on melanoma clones, isolated from a single tumor characterized by mutually exclusive expression of BRAFV600E and NRASQ61R in different cells. This effort led us to identify two genes, SEMA6A and MICAL1, highly expressed in BRAF-mutant vs NRAS-mutant clones. Real-time PCR, Western blot and immunohistochemistry confirmed preferential expression of Sema6A and Mical1 in BRAFV600E melanoma. Sema6A is a member of the semaphorin family, and it complexes with the plexins to regulate actin cytoskeleton, motility and cell proliferation. Silencing of Sema6A in BRAF-mutant cells caused cytoskeletal remodeling, and loss of stress fibers, that in turn induced cell death. Furthermore, Sema6A depletion caused loss of anchorage-independent growth, inhibition of chemotaxis and invasion. Forced Sema6A overexpression, in NRASQ61R clones, induced anchorage-independent growth, and a significant increase of invasiveness. Mical1, that links Sema/PlexinA signaling, is also a negative regulator of apoptosis. Indeed, Mical-1 depletion in BRAF mutant cells restored MST-1-dependent NDR phosphorylation and promoted a rapid and massive NDR-dependent apoptosis. Overall, our data suggest that Sema6A and Mical1 may represent new potential therapeutic targets in BRAFV600E melanoma.

Original languageEnglish
Pages (from-to)2763-2777
Number of pages15
JournalOncotarget
Volume6
Issue number5
Publication statusPublished - 2015

Fingerprint

Melanoma
Cell Survival
Clone Cells
Growth
Cell Migration Inhibition
Semaphorins
Apoptosis
Stress Fibers
Microarray Analysis
Actin Cytoskeleton
Genes
Real-Time Polymerase Chain Reaction
Cell Death
Western Blotting
Immunohistochemistry
Phosphorylation
Cell Proliferation
Genome
Neoplasms
Therapeutics

Keywords

  • BRAF melanoma
  • Cell survival
  • Mical1
  • NRAS melanoma
  • Sema6A

ASJC Scopus subject areas

  • Oncology

Cite this

Loria, R., Bon, G., Perotti, V., Gallo, E., Bersani, I., Baldassari, P., ... Falcioni, R. (2015). Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells. Oncotarget, 6(5), 2763-2777.

Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells. / Loria, Rossella; Bon, Giulia; Perotti, Valentina; Gallo, Enzo; Bersani, Ilaria; Baldassari, Paola; Porru, Manuela; Leonetti, Carlo; Carlo, Selene Di; Visca, Paolo; Brizzi, Maria Felice; Anichini, Andrea; Mortarini, Roberta; Falcioni, Rita.

In: Oncotarget, Vol. 6, No. 5, 2015, p. 2763-2777.

Research output: Contribution to journalArticle

Loria, R, Bon, G, Perotti, V, Gallo, E, Bersani, I, Baldassari, P, Porru, M, Leonetti, C, Carlo, SD, Visca, P, Brizzi, MF, Anichini, A, Mortarini, R & Falcioni, R 2015, 'Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells', Oncotarget, vol. 6, no. 5, pp. 2763-2777.
Loria R, Bon G, Perotti V, Gallo E, Bersani I, Baldassari P et al. Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells. Oncotarget. 2015;6(5):2763-2777.
Loria, Rossella ; Bon, Giulia ; Perotti, Valentina ; Gallo, Enzo ; Bersani, Ilaria ; Baldassari, Paola ; Porru, Manuela ; Leonetti, Carlo ; Carlo, Selene Di ; Visca, Paolo ; Brizzi, Maria Felice ; Anichini, Andrea ; Mortarini, Roberta ; Falcioni, Rita. / Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells. In: Oncotarget. 2015 ; Vol. 6, No. 5. pp. 2763-2777.
@article{d2b04d4637fd49189bfa697e31123793,
title = "Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells",
abstract = "We used whole genome microarray analysis to identify potential candidate genes with differential expression in BRAFV600E vs NRASQ61R melanoma cells. We selected, for comparison, a peculiar model based on melanoma clones, isolated from a single tumor characterized by mutually exclusive expression of BRAFV600E and NRASQ61R in different cells. This effort led us to identify two genes, SEMA6A and MICAL1, highly expressed in BRAF-mutant vs NRAS-mutant clones. Real-time PCR, Western blot and immunohistochemistry confirmed preferential expression of Sema6A and Mical1 in BRAFV600E melanoma. Sema6A is a member of the semaphorin family, and it complexes with the plexins to regulate actin cytoskeleton, motility and cell proliferation. Silencing of Sema6A in BRAF-mutant cells caused cytoskeletal remodeling, and loss of stress fibers, that in turn induced cell death. Furthermore, Sema6A depletion caused loss of anchorage-independent growth, inhibition of chemotaxis and invasion. Forced Sema6A overexpression, in NRASQ61R clones, induced anchorage-independent growth, and a significant increase of invasiveness. Mical1, that links Sema/PlexinA signaling, is also a negative regulator of apoptosis. Indeed, Mical-1 depletion in BRAF mutant cells restored MST-1-dependent NDR phosphorylation and promoted a rapid and massive NDR-dependent apoptosis. Overall, our data suggest that Sema6A and Mical1 may represent new potential therapeutic targets in BRAFV600E melanoma.",
keywords = "BRAF melanoma, Cell survival, Mical1, NRAS melanoma, Sema6A",
author = "Rossella Loria and Giulia Bon and Valentina Perotti and Enzo Gallo and Ilaria Bersani and Paola Baldassari and Manuela Porru and Carlo Leonetti and Carlo, {Selene Di} and Paolo Visca and Brizzi, {Maria Felice} and Andrea Anichini and Roberta Mortarini and Rita Falcioni",
year = "2015",
language = "English",
volume = "6",
pages = "2763--2777",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "5",

}

TY - JOUR

T1 - Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells

AU - Loria, Rossella

AU - Bon, Giulia

AU - Perotti, Valentina

AU - Gallo, Enzo

AU - Bersani, Ilaria

AU - Baldassari, Paola

AU - Porru, Manuela

AU - Leonetti, Carlo

AU - Carlo, Selene Di

AU - Visca, Paolo

AU - Brizzi, Maria Felice

AU - Anichini, Andrea

AU - Mortarini, Roberta

AU - Falcioni, Rita

PY - 2015

Y1 - 2015

N2 - We used whole genome microarray analysis to identify potential candidate genes with differential expression in BRAFV600E vs NRASQ61R melanoma cells. We selected, for comparison, a peculiar model based on melanoma clones, isolated from a single tumor characterized by mutually exclusive expression of BRAFV600E and NRASQ61R in different cells. This effort led us to identify two genes, SEMA6A and MICAL1, highly expressed in BRAF-mutant vs NRAS-mutant clones. Real-time PCR, Western blot and immunohistochemistry confirmed preferential expression of Sema6A and Mical1 in BRAFV600E melanoma. Sema6A is a member of the semaphorin family, and it complexes with the plexins to regulate actin cytoskeleton, motility and cell proliferation. Silencing of Sema6A in BRAF-mutant cells caused cytoskeletal remodeling, and loss of stress fibers, that in turn induced cell death. Furthermore, Sema6A depletion caused loss of anchorage-independent growth, inhibition of chemotaxis and invasion. Forced Sema6A overexpression, in NRASQ61R clones, induced anchorage-independent growth, and a significant increase of invasiveness. Mical1, that links Sema/PlexinA signaling, is also a negative regulator of apoptosis. Indeed, Mical-1 depletion in BRAF mutant cells restored MST-1-dependent NDR phosphorylation and promoted a rapid and massive NDR-dependent apoptosis. Overall, our data suggest that Sema6A and Mical1 may represent new potential therapeutic targets in BRAFV600E melanoma.

AB - We used whole genome microarray analysis to identify potential candidate genes with differential expression in BRAFV600E vs NRASQ61R melanoma cells. We selected, for comparison, a peculiar model based on melanoma clones, isolated from a single tumor characterized by mutually exclusive expression of BRAFV600E and NRASQ61R in different cells. This effort led us to identify two genes, SEMA6A and MICAL1, highly expressed in BRAF-mutant vs NRAS-mutant clones. Real-time PCR, Western blot and immunohistochemistry confirmed preferential expression of Sema6A and Mical1 in BRAFV600E melanoma. Sema6A is a member of the semaphorin family, and it complexes with the plexins to regulate actin cytoskeleton, motility and cell proliferation. Silencing of Sema6A in BRAF-mutant cells caused cytoskeletal remodeling, and loss of stress fibers, that in turn induced cell death. Furthermore, Sema6A depletion caused loss of anchorage-independent growth, inhibition of chemotaxis and invasion. Forced Sema6A overexpression, in NRASQ61R clones, induced anchorage-independent growth, and a significant increase of invasiveness. Mical1, that links Sema/PlexinA signaling, is also a negative regulator of apoptosis. Indeed, Mical-1 depletion in BRAF mutant cells restored MST-1-dependent NDR phosphorylation and promoted a rapid and massive NDR-dependent apoptosis. Overall, our data suggest that Sema6A and Mical1 may represent new potential therapeutic targets in BRAFV600E melanoma.

KW - BRAF melanoma

KW - Cell survival

KW - Mical1

KW - NRAS melanoma

KW - Sema6A

UR - http://www.scopus.com/inward/record.url?scp=84923300954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923300954&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 2763

EP - 2777

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 5

ER -